CD4 lymphoctye percentage versus absolute CD4 lymphocyte count in predicting HIV disease progression: An old debate revisited

被引:20
作者
Goicoechea, M [1 ]
Haubrich, R [1 ]
机构
[1] Univ Calif San Diego, Dept Med, Div Infect Dis, San Diego, CA 92103 USA
关键词
D O I
10.1086/432972
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:945 / 947
页数:3
相关论文
共 13 条
[1]  
[Anonymous], 2008, Guidelines for the Use of Antiretroviral Agents in HIV-1- Infected adults and Adolescents
[2]   CD4-PERCENT IS THE BEST PREDICTOR OF DEVELOPMENT OF AIDS IN A COHORT OF HIV-INFECTED HOMOSEXUAL MEN [J].
BURCHAM, J ;
MARMOR, M ;
DUBIN, N ;
TINDALL, B ;
COOPER, DA ;
BERRY, G ;
PENNY, R .
AIDS, 1991, 5 (04) :365-372
[3]   Absolute CD4 vs. CD4 percentage for predicting the risk of opportunistic illness in HIV infection [J].
Gebo, KA ;
Gallant, JE ;
Keruly, JC ;
Moore, RD .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (05) :1028-1033
[4]   WITHIN-SUBJECT VARIATION IN CD4 LYMPHOCYTE COUNT IN ASYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - IMPLICATIONS FOR PATIENT MONITORING [J].
HUGHES, MD ;
STEIN, DS ;
GUNDACKER, HM ;
VALENTINE, FT ;
PHAIR, JP ;
VOLBERDING, PA .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (01) :28-36
[5]   CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3 [J].
Hulgan, T ;
Raffanti, S ;
Kheshti, A ;
Blackwell, RB ;
Rebeiro, PF ;
Barkanic, G ;
Ritz, B ;
Sterling, TR .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (06) :950-957
[6]  
Le TP, 1997, AIDS, V11, P1395
[7]   When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study [J].
Lepri, AC ;
Phillips, AN ;
Monforte, AD ;
Castelli, F ;
Antinori, A ;
de Luca, A ;
Pezzotti, P ;
Alberici, F ;
Cargnel, A ;
Grima, P ;
Piscopo, R ;
Prestileo, T ;
Scalise, G ;
Vigevani, M ;
Moroni, M .
AIDS, 2001, 15 (08) :983-990
[8]   Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: evaluation of Beckman Coulter flow-count fluorospheres and the tetraONE system [J].
Reimann, KA ;
O'Gorman, MRG ;
Spritzler, J ;
Wilkening, CL ;
Sabath, DE ;
Helm, K ;
Campbell, DE .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (03) :344-351
[9]   Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: Longer follow-up of an observational cohort study [J].
Sterling, TR ;
Chaisson, RE ;
Keruly, J ;
Moore, RD .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (11) :1659-1665
[10]  
TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114